Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Essilorluxottica's other long-term liabilities for the quarter that ended in Dec. 2025 was $2,593 Mil.
Essilorluxottica's quarterly other long-term liabilities
increased
from Dec. 2024 ($2,494 Mil) to Jun. 2025 ($2,610 Mil) but then
declined
from Jun. 2025 ($2,610 Mil) to Dec. 2025 ($2,593 Mil).
Essilorluxottica's annual other long-term liabilities
declined
from Dec. 2023 ($2,711 Mil) to Dec. 2024 ($2,494 Mil) but then
increased
from Dec. 2024 ($2,494 Mil) to Dec. 2025 ($2,593 Mil).
Essilorluxottica Other Long-Term Liabilities Related Terms
Essilorluxottica Other Long-Term Liabilities Historical Data
* Premium members only.
The historical data trend for Essilorluxottica's Other Long-Term Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Essilorluxottica Other Long-Term Liabilities Chart
Essilorluxottica Other Long-Term Liabilities Calculation
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
What does a Other Long-Term Liabilities of $2,593 Mil mean?
Essilorluxottica (ESLOF) has a Other Long-Term Liabilities of $2,593 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Essilorluxottica and its competitors.
Is Essilorluxottica's Other Long-Term Liabilities too high?
Essilorluxottica's current Other Long-Term Liabilities is $2,593 Mil. Overall, Essilorluxottica has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Essilorluxottica's Other Long-Term Liabilities compare to ISRG and BDX?
Essilorluxottica's Other Long-Term Liabilities of $2,593 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Essilorluxottica and its competitors. Essilorluxottica's current Other Long-Term Liabilities is $2,593 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Essilorluxottica stock overvalued right now?
Based on GuruFocus' analysis, Essilorluxottica (ESLOF) is currently considered Significantly Undervalued. The stock's GF Value™ is $274.13, compared to a current price of $188.13 — trading 31.4% below its estimated fair value. The current Other Long-Term Liabilities is $2,593 Mil. Essilorluxottica's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Essilorluxottica (ESLOF), the current Other Long-Term Liabilities is $2,593 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Essilorluxottica (ESLOF) Overvalued in 2026?
Based on GuruFocus' analysis, Essilorluxottica stock appears to be undervalued.
The current stock price of $188.13 is trading 31.4% below its estimated GF Value™ of $274.13.
GuruFocus considers Essilorluxottica to be Significantly Undervalued.
Key valuation signals for ESLOF:
Other Long-Term Liabilities: $2,593 Mil
GF Value™: $274.13 vs. price of $188.13 (31.4% below fair value)
No single metric tells the full story. See the ESLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest competitor and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 37% of sales in Europe, 45% in North America, and the rest in Asia and Latin America.
78GF Score
Get the complete analysis for ESLOF
Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESLOF has been successfully added to your 
